Ionis Pharmaceuticals Strategic Investments
Corporate venture profile
Ionis Pharmaceuticals Strategic Investments is the corporate venture arm of Ionis Pharmaceuticals, a pharmaceutical and biotech company. It is based in Carlsbad, United States. It invests at the Series A stage. Sectors it names: biotech and life sciences.
Every figure links to its source
Snapshot
Data behind this graphic
| Item | Value |
|---|---|
| Stage range | Series A to Series A |
| Sectors | Biotech and life sciences |
| Geography | North America |
| Offices | Carlsbad, United States |
Sources: S2 Business Wire: Aro Biotherapeutics announces $88 million Series A financing.
Where it invests
Key facts
| Fact | Value | Status | Source |
|---|---|---|---|
| Parent company | Ionis Pharmaceuticals (Nasdaq: IONS) | Single source | S1 |
| Parent industry | Pharmaceuticals and biotech | Single source | S1 |
| Headquarters | Carlsbad, United States | Single source | S1 |
| Status | Active | Single source | S1 |
| Capital source | Parent company only | Single source | S1 |
| Stages | Series A (inferred from announced rounds) | Estimate | S2 |
About Ionis Pharmaceuticals
Recent rounds
| Date | Company | Round | Amount | Led by the firm | Source |
|---|---|---|---|---|---|
| 2021-01-05 | Aro Biotherapeutics | Series A | USD 88M | No | S2 |
Portfolio
Portfolio company named in public sources: Aro Biotherapeutics.S2
Official pages
Read the firm's own pages for current information.
- Website www.ionis.com/
Sources
Disclaimer and corrections
Not affiliated. This page is not affiliated with, endorsed by or sponsored by Ionis Pharmaceuticals Strategic Investments or any company named on it. Names and trademarks belong to their owners. Informational only. This is a public-source reference. It is not investment, legal or tax advice and not an offer or solicitation. Sources. Each figure names its source. Figures may have changed. Please read the firm's official pages, linked above. Corrections and takedown. To report an error or ask for a change or removal, use the correction form or email Richard@CorporateVentureCapital.com.
Spotted a mistake? Report a correction.